Are You Experiencing Persistent Abdominal Pain in IBS?

The CAPTIVATE Study will evaluate whether an oral investigational study medication (olorinab) may reduce abdominal pain associated with IBS.

Take a
stand against
IBS pain.

Join CAPTIVATE.

See If You May Qualify
CAN I PARTICIPATE?
You may be able to take part in the CAPTIVATE IBS pain trial if you:

Are 18-70 years of age

Have been diagnosed with IBS with constipation or diarrhea (IBS-C or IBS-D)

Experience abdominal pain due to IBS

Other eligibility criteria apply.

QUALIFIED PARTICIPANTS IN THE CAPTIVATE TRIAL WILL:

  • Potentially get access to the investigational medication
  • Be seen and monitored by IBS experts
  • Help advance IBS research

All study treatment and study-related care will be provided at no cost.  Payment will be provided for each completed study visit.

See If You May Qualify

Irritable Bowel Syndrome (IBS) is an intestinal disorder characterized by abdominal pain and altered bowel habits. Many people with IBS say abdominal pain is the symptom that bothers them the most.

0 Million

people in the United States are affected by IBS.

The impact of IBS can range from mild inconvenience to severe debilitation.

The most common symptoms are:

  • Abdominal Pain
  • Diarrhea
  • Constipation
  • Gas
  • Bloating

About

0 out of 3

affected people are adult females.

Many patients describe abdominal pain as the most bothersome symptom of their IBS.

75% of patients report daily/weekly recurring pain.

Sources: AboutIBS.org | IBS in America AGA 2015, Hungin et al, IBS In US: prevalence, symptom patterns and impact, 2005. | AGA Patient Survey, IBS In America, December 2015.

The CAPTIVATE Study will evaluate if an oral investigational study medication (olorinab) may reduce abdominal pain associated with IBS.

See If You May Qualify